Literature DB >> 8344108

Prophylactic versus emergency sclerotherapy of large esophageal varices prior to liver transplantation.

D H Van Thiel1, V J Dindzans, R R Schade, M Rabinovitz, J S Gavaler.   

Abstract

From January 1985 through July 1987, adult patients accepted for liver transplantation with large esophageal varices were enrolled in a study evaluating the use of prophylactic vs emergency sclerotherapy. Six hundred forty-eight subjects received prophylactic sclerotherapy, and 172 received emergent sclerotherapy. Esophageal stricture formation was increased 12.9-fold (P < 0.001), esophageal perforation 6.4-fold (P < 0.005), and postsclerotherapy bleeding esophageal ulcers 3.7-fold (P < 0.001) in those receiving emergency sclerotherapy as opposed to prophylactic sclerotherapy. These differences were even greater if the number of sclerotherapy sessions rather than the number of patients was used as the denominator for the comparisons. In total, 19.6% of emergency sclerotherapy cases were associated with an untoward outcome of sclerotherapy; only 1.9% of cases receiving prophylactic sclerotherapy experienced an untoward outcome (P < 0.001). These data demonstrate that emergency sclerotherapy is associated with a greater prevalence of complications and support earlier studies that show that sclerotherapy prevents variceal bleeding over the short term. The data also suggest that when applied to patients with large varices awaiting orthotopic liver transplantation, it enhances the chance of a patient surviving to be transplanted by preventing a variceal bleed and the spiral of liver failure and death that frequently follows an episode of acute variceal bleeding.

Entities:  

Mesh:

Year:  1993        PMID: 8344108     DOI: 10.1007/bf01308612

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  The role of sclerotherapy in the treatment of esophageal varices: personal experience and a review of randomized trials.

Authors:  H Snady
Journal:  Am J Gastroenterol       Date:  1987-09       Impact factor: 10.864

2.  Pathological findings in the esophagus after endoscopic sclerotherapy for variceal bleeding.

Authors:  C Pushpanathan; H Idikio
Journal:  Am J Gastroenterol       Date:  1986-01       Impact factor: 10.864

Review 3.  Liver transplantation: an overview.

Authors:  W C Maddrey; D H Van Thiel
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

4.  Correlation between size of esophageal varices and risk of gastrointestinal hemorrhage: clinical and esophagoscopic study.

Authors:  A K Goyal; S K Goyal; D S Pokharna; S K Sharma
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

5.  Solitary brain abscess following endoscopic injection sclerosis of esophageal varices.

Authors:  F L Cohen; R S Koerner; S J Taub
Journal:  Gastrointest Endosc       Date:  1985-10       Impact factor: 9.427

6.  Fatal complication of endoscopic sclerotherapy: Serratia marcescens bacteremia with delayed esophageal perforation.

Authors:  W McGrew; J Goodin; W Stuck
Journal:  Gastrointest Endosc       Date:  1985-10       Impact factor: 9.427

7.  Endoscopic sclerotherapy using absolute alcohol.

Authors:  S K Sarin; G K Sachdeva; R Nanda; J C Vij; B S Anand
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

8.  Effects of sodium tetradecyl sulfate endoscopic variceal sclerotherapy on the esophagus. A prospective clinical and histopathologic study.

Authors:  M Kage; J Korula; A Harada; F Mucientes; G Kanel; R L Peters
Journal:  J Clin Gastroenterol       Date:  1987-12       Impact factor: 3.062

9.  Two-year experience of management of bleeding esophageal varices with a coordinated treatment program based on injection sclerotherapy.

Authors:  P D Wright; H W Loose; R F Carter; O F James
Journal:  Surgery       Date:  1986-05       Impact factor: 3.982

10.  Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial.

Authors:  D Westaby; B R Macdougall; R Williams
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

View more
  3 in total

1.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

2.  Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Danielle Roberts; Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Sivapatham Arunan; Tanjia Begum; Norman R Williams; Dana Walshaw; Elisabeth Jane Milne; Maxine Tapp; Mario Csenar; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-10

3.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.